Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Septerna, Inc. - Common Stock
(NQ:
SEPN
)
29.02
-1.26 (-4.16%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Septerna, Inc. - Common Stock
< Previous
1
2
Next >
Septerna to Present at TD Cowen 46th Annual Health Care Conference
February 24, 2026
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 10, 2026
From
Septerna, Inc.
Via
GlobeNewswire
Septerna to Present Data from Phase 1 Clinical Trial of SEP-631 for the Treatment of Mast Cell-Driven Diseases at 2026 AAAAI Annual Meeting
February 10, 2026
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
January 08, 2026
From
Septerna, Inc.
Via
GlobeNewswire
Septerna to Present at 44th Annual J.P. Morgan Healthcare Conference
December 17, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna to Participate in 8th Annual Evercore Healthcare Conference
November 25, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Highlights Company Progress and Reports Third Quarter 2025 Financial Results
November 10, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna to Participate in Upcoming Investor Conferences
November 03, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
↗
October 15, 2025
Novo Nordisk’s $4.7B Akero deal boosts its metabolic health pipeline, targeting Eli Lilly’s lead in obesity and liver disease treatments
Via
MarketBeat
Topics
World Trade
Septerna Appoints Veteran Biotechnology Leader Keith Gottesdiener, M.D., to its Board of Directors
September 29, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna to Participate in Upcoming Investor Conferences
August 27, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
August 21, 2025
Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-631 in Healthy Volunteers
From
Septerna, Inc.
Via
GlobeNewswire
Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results
August 11, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside
↗
June 23, 2025
Septerna gains Buy rating as HC Wainwright highlights undervaluation, strong pipeline, and key partnership with Novo Nordisk in metabolic diseases.
Via
Benzinga
This Ventas Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
↗
June 23, 2025
Via
Benzinga
This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
June 23, 2025
Via
Benzinga
The Analyst Verdict: Septerna In The Eyes Of 4 Experts
↗
June 23, 2025
Via
Benzinga
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
↗
May 29, 2025
Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?
Via
Investor's Business Daily
Septerna to Present at Jefferies Global Healthcare Conference
May 29, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Analysts Think These Stocks Could More Than Double in Value
May 23, 2025
Septerna, Intellia, and Novavax have garnered investor attention for their significant upside potential, but investors should beware the risks as well.
Via
MarketBeat
Topics
World Trade
Where Septerna Stands With Analysts
↗
May 16, 2025
Via
Benzinga
3 Stocks That Will Profit From Trump's Drug Price Cut
↗
May 16, 2025
Trump's EO aims to lower US drug prices by using leverage of public programs (like Medicare) to force accountability. Big pharma may be hit hardest.
Via
Benzinga
Topics
Government
Ozempic Maker Novo Nordisk Looks For New Chief, Jørgensen Steps Down From CEO Role
↗
May 16, 2025
Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains optimistic amid mixed signals.
Via
Benzinga
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
May 15, 2025
From
Septerna, Inc.
Via
GlobeNewswire
Which stocks have an unusual volume on Thursday?
↗
May 15, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session.
Via
Chartmill
Is It Time to Buy the Dip in Novo Nordisk Stock?
May 15, 2025
Novo Nordisk stock is down nearly 50% in 2025 as competition in the GLP-1 space continues to mount, but the fundamental case for the NVO stock is growing
Via
MarketBeat
Topics
Government
Top movers analysis in the middle of the day on 2025-05-14: top gainers and losers in today's session.
↗
May 14, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Money Movers: HIT, SEPN, ALUR, LUCY, PRSO – Biotech, Healthcare, AI & Weight Loss Innovators Lead Momentum Surge – More Stocks Inside
May 14, 2025
Via
AB Newswire
Topics
Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 14, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
May 14, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
